Aviance Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.65M | Sell |
89,080
-94,050
| -51% | -$4.91M | 0.7% | 45 |
|
|
2018
Q4 | $8.75M | Buy |
183,130
+52,951
| +41% | +$2.53M | 1.23% | 24 |
|
|
2018
Q3 | $6.54M | Buy |
130,179
+123,610
| +1,882% | +$6.21M | 0.64% | 43 |
|
|
2018
Q2 | $331K | Sell |
6,569
-502
| -7% | -$25.3K | 0.03% | 141 |
|
|
2018
Q1 | $345K | Buy |
7,071
+89
| +1% | +$4.34K | 0.03% | 168 |
|
|
2017
Q4 | $310K | Sell |
6,982
-82,708
| -92% | -$3.67M | 0.02% | 162 |
|
|
2017
Q3 | $4.55M | Sell |
89,690
-10,172
| -10% | -$516K | 0.31% | 58 |
|
|
2017
Q2 | $5.38M | Sell |
99,862
-14,854
| -13% | -$801K | 0.34% | 62 |
|
|
2017
Q1 | $6.05M | Sell |
114,716
-10,742
| -9% | -$566K | 0.34% | 63 |
|
|
2016
Q4 | $6.04M | Sell |
125,458
-558,254
| -82% | -$26.9M | 0.32% | 66 |
|
|
2016
Q3 | $36.9M | Sell |
683,712
-18,074
| -3% | -$974K | 1.02% | 25 |
|
|
2016
Q2 | $38M | Buy |
701,786
+282,198
| +67% | +$15.3M | 1.14% | 23 |
|
|
2016
Q1 | $21.3M | Buy |
419,588
+97,954
| +30% | +$4.97M | 0.7% | 41 |
|
|
2015
Q4 | $16.2M | Buy |
321,634
+59,371
| +23% | +$2.99M | 0.53% | 53 |
|
|
2015
Q3 | $12.6M | Buy |
+262,263
| New | +$12.6M | 0.44% | 59 |
|
|
2015
Q2 | – | Sell |
-186,692
| Closed | -$10.8M | – | 125 |
|
|
2015
Q1 | $10.8M | Sell |
186,692
-204,142
| -52% | -$11.8M | 0.4% | 54 |
|
|
2014
Q4 | $20.9M | Sell |
390,834
-55,968
| -13% | -$2.99M | 0.75% | 43 |
|
|
2014
Q3 | $25.7M | Buy |
446,802
+83,061
| +23% | +$4.77M | 1.03% | 28 |
|
|
2014
Q2 | $24.3M | Buy |
363,741
+128,771
| +55% | +$8.61M | 1.03% | 24 |
|
|
2014
Q1 | $15.7M | Buy |
234,970
+229,452
| +4,158% | +$15.3M | 0.8% | 34 |
|
|
2013
Q4 | $368K | Buy |
5,518
+267
| +5% | +$17.8K | 0.2% | 89 |
|
|
2013
Q3 | $329K | Sell |
5,251
-22,442
| -81% | -$1.41M | 0.19% | 98 |
|
|
2013
Q2 | $1.73M | Buy |
+27,693
| New | +$1.73M | 0.95% | 35 |
|